Literature DB >> 28491714

Delayed cardiac perforation of the Durata implantable cardioverter-defibrillator lead more than 1 year after implantation.

Sandeep K Sharma1, Jonathan W Weinsaft1, James E Ip1, Jim W Cheung1.   

Abstract

Entities:  

Keywords:  Cardiac perforation; Defibrillator lead; Pericardial effusion

Year:  2016        PMID: 28491714      PMCID: PMC5419938          DOI: 10.1016/j.hrcr.2016.04.005

Source DB:  PubMed          Journal:  HeartRhythm Case Rep        ISSN: 2214-0271


× No keyword cloud information.

Introduction

KEY TEACHING POINTS This case report describes a case of delayed perforation of the Durata implantable cardioverter-defibrillator lead more than 1 year after implantation. Lead perforation led to a late presentation of pericardial effusion with cardiac tamponade. This case report highlights the importance of continued vigilance for mechanical complications of lead placement even more than 1 year after implantation. The rate of implantable cardioverter-defibrillator (ICD) lead perforations has been reported to be in the range of 0.6%–5.2%, with the majority of cases occurring within 1 month of implantation. However, isolated reports of delayed ICD lead perforations occurring more than 1 year and up to 3 years after implantation have been described.2, 3, 4 Here, we present a case of a patient with a Durata ICD lead who presented with syncope and cardiac tamponade due to lead perforation more than 1 year after implantation.

Case report

A 40-year-old man with a history of Brugada syndrome underwent implantation of an ICD with a Durata 7122Q lead (St. Jude Medical, St. Paul, MN) at an outside hospital. The procedure was performed uneventfully. At the time of implantation, the patient had a ventricular R-wave amplitude of 11.9 mV, a pacing threshold of 1.0 V at 0.5 ms, and a lead impedance of 508 Ω. He had an in-office interrogation 8 months later, which revealed a ventricular R-wave amplitude of 11.7 mV, a pacing threshold of 1.25 V at 0.5 ms, and a lead impedance of 310 Ω. Fourteen months after device implantation, he experienced intermittent left shoulder pain. An echocardiogram showed no pericardial effusion. He was admitted to our hospital 2 weeks afterward with syncope. A transthoracic echocardiogram showed a large pericardial effusion with the defibrillator lead tip lodged in the pericardial space (Figure 1 and Online Supplemental Video). Device interrogation revealed a decreased ventricular R-wave amplitude of 1.2 mV, an elevated right ventricular pacing threshold of 4.5 V at 0.5 ms, and a decreased lead impedance of 190 Ω that had trended down from normal levels within a 1-month period. Pericardiocentesis was performed, and 600 cm3 of hemorrhagic fluid was drained. The patient underwent device and lead removal in a hybrid operating room without need for further intervention and was discharged 2 days later.
Figure 1

Video still of an apical 4-chamber view of the transthoracic echocardiogram of the case patient. Pericardial effusion is present along the right ventricle with the Durata lead tip visualized in the pericardial space, confirming perforation.

Discussion

To our knowledge, this case is the first report of delayed Durata lead perforation occurring more than 1 year after implantation. Concerns about delayed cardiac perforations with small diameter ICD leads, mainly involving the St. Jude Riata lead, have been raised by single-center studies.5, 6 In these series, all perforations occurred within 6 weeks of lead implantation. Similarly, 2 previously published cases of delayed cardiac perforation with the Durata lead occurred within 6 weeks of implantation.7, 8 The mechanism behind the marked delay (>1 year) in the occurrence of lead perforation in this patient is unclear. This patient did not have known risk factors for lead perforation, such as steroid use, low body mass index, or older age. The design of the Durata lead incorporates a curve along the right ventricular shock coil with a flanged silicone tip to reduce lead tip pressure and potentially reduce the risk of cardiac perforation. It has been postulated that the preformed slight curvature of the Durata lead may lead to unpredictable rotation of the lead body screw deployment that may lead to perforation. In addition, despite the presence of a flanged silicone tip, the decreased lead diameter may still lead to increased pressure at the lead tip, resulting in cardiac perforation. Between the time of implantation and follow-up 8 months later, that patient has a mild decrease in the lead impedance and minimal elevation of the pacing threshold, which may have reflected minimal migration of the lead tip. It is possible that over time, with continued cardiac motion, the lead gradually advanced into the pericardial space over a period of several months before the acute formation of a pericardial effusion and onset of symptoms. This case underscores the importance of vigilance for delayed mechanical complications of ICD lead placement even more than 1 year after lead implantation.

KEY TEACHING POINTS

This case report describes a case of delayed perforation of the Durata implantable cardioverter-defibrillator lead more than 1 year after implantation.

Lead perforation led to a late presentation of pericardial effusion with cardiac tamponade.

This case report highlights the importance of continued vigilance for mechanical complications of lead placement even more than 1 year after implantation.

  10 in total

1.  Long-term complication rates in ventricular, single lead VDD, and dual chamber pacing.

Authors:  Uwe K H Wiegand; Frank Bode; Hendrik Bonnemeier; Frank Eberhard; Monika Schlei; Werner Peters
Journal:  Pacing Clin Electrophysiol       Date:  2003-10       Impact factor: 1.976

2.  Delayed ICD lead cardiac perforation: comparison of small versus standard-diameter leads implanted in a single center.

Authors:  Roberto Rordorf; Fabio Canevese; Alessandro Vicentini; Barbara Petracci; Simone Savastano; Antonio Sanzo; Edoardo Gandolfi; Roberto Dore; Maurizio Landolina
Journal:  Pacing Clin Electrophysiol       Date:  2011-01-05       Impact factor: 1.976

Review 3.  Delayed lead perforation: a disturbing trend.

Authors:  Mohammed N Khan; George Joseph; Yaariv Khaykin; Khaled M Ziada; Bruce L Wilkoff
Journal:  Pacing Clin Electrophysiol       Date:  2005-03       Impact factor: 1.976

4.  Delayed cardiac perforation by one small body diameter defibrillator lead.

Authors:  Majid Haghjoo; Abolfath Alizadeh; Amir Farjam Fazelifar; Mozhgan Hajahmadi; Mohammad Ali Sadr-Ameli
Journal:  J Electrocardiol       Date:  2010 Jan-Feb       Impact factor: 1.438

5.  Acute perforation in spite of implantation with an "antiperforation" defibrillator lead.

Authors:  Walter W Chien; John Chin
Journal:  Pacing Clin Electrophysiol       Date:  2009-09-10       Impact factor: 1.976

6.  Late perforation of Durata ICD lead--a case report.

Authors:  Bharati Das; Sachin Yalagudri; S Maiya; Sunita Abhraham; J Kannan; Ravi Kishore
Journal:  Indian Heart J       Date:  2014 Jul-Aug

7.  Incidence and predictors of cardiac perforation after permanent pacemaker placement.

Authors:  Srijoy Mahapatra; Kevin A Bybee; T Jared Bunch; Raul E Espinosa; Lawrence J Sinak; Michael D McGoon; David L Hayes
Journal:  Heart Rhythm       Date:  2005-09       Impact factor: 6.343

8.  Proper management of pericardial tamponade as a late complication of implantable cardiac device placement.

Authors:  Glenn M Polin; Erica Zado; Hemal Nayak; Joshua M Cooper; Andrea M Russo; Sanjay Dixit; David Lin; Francis E Marchlinski; Ralph J Verdino
Journal:  Am J Cardiol       Date:  2006-05-11       Impact factor: 2.778

9.  Recurrent pericardial chest pain: a case of late right ventricular perforation after implantation of a transvenous active-fixation ICD lead.

Authors:  J Kautzner; J Bytesník
Journal:  Pacing Clin Electrophysiol       Date:  2001-01       Impact factor: 1.976

10.  Timing of delayed perforation with the St. Jude Riata lead: a single-center experience and a review of the literature.

Authors:  Stephan B Danik; Moussa Mansour; E Kevin Heist; Patrick Ellinor; David Milan; Jagmeet Singh; Saumya Das; Vivek Reddy; Andre D'Avila; Jeremy N Ruskin; Theofanie Mela
Journal:  Heart Rhythm       Date:  2008-09-16       Impact factor: 6.343

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.